文献速递妇科

宫腔镜与腹腔镜绝育术后的以患者为中心的安全性结局比较

Patient-Centered Safety Outcomes After Hysteroscopic Compared With Laparoscopic Sterilization.
PubMed 文献 · Obstet Gynecol · 2022-01-01

该回顾性队列研究基于2008至2014年加州医疗补助索赔数据,纳入5906例子宫腔镜绝育术和23965例腹腔镜绝育术女性,经倾向加权和回归调整后比较安全性结局。宫腔镜绝育术重复绝育索赔更多(1年调整发生率比3.48,95%CI 2.69-4.27),异常子宫出血索赔更多,但手术并发症及盆腔痛、腹痛索赔更少。

要点

  • 宫腔镜绝育术后1年重复绝育索赔的调整发生率比为3.48(95%CI 2.69-4.27),高于腹腔镜绝育术。
  • 宫腔镜绝育术后手术并发症(如输血)索赔更少(P<.001),术后2-3个月额外手术(如子宫切除)索赔更少(P=.002)。
  • 宫腔镜绝育术后盆腔痛(2年调整发生率比0.77,95%CI 0.65-0.92)和腹痛索赔更少,但术后7-12个月异常子宫出血索赔更多(调整发生率比1.37,95%CI 1.06-1.77)。

核心结论

  • 与腹腔镜绝育术相比,宫腔镜绝育术后重复绝育手术和异常子宫出血的索赔更多,但手术并发症及盆腔痛或腹痛索赔更少。

研究设计与样本

  • 回顾性队列研究,使用2008至2014年加州医疗补助索赔数据,纳入18-50岁接受宫腔镜或腹腔镜绝育术的女性,排除产后手术。
  • 宫腔镜绝育术组5906例,腹腔镜绝育术组23965例;采用对数线性(泊松)事件历史回归模型,对聚类人物-时期数据加权倾向并调整社会人口学和临床特征。

主要发现

  • 宫腔镜绝育术组手术当日手术并发症(如输血)索赔少于腹腔镜绝育术组(P<.001),术后2-3个月额外手术(如子宫切除)索赔少于腹腔镜绝育术组(P=.002)。
  • 宫腔镜绝育术组1年内重复绝育索赔调整发生率比为3.48(95%CI 2.69-4.27),5年内为2.32(95%CI 1.84-2.79),均高于腹腔镜绝育术组。
  • 宫腔镜绝育术组2年盆腔痛索赔调整发生率比为0.77(95%CI 0.65-0.92),7-12个月腹痛为0.80(95%CI 0.68-0.93),2年盆腔炎性疾病为0.55(95%CI 0.33-0.93),均低于腹腔镜绝育术组。
  • 宫腔镜绝育术组术后7-12个月异常子宫出血索赔调整发生率比为1.37(95%CI 1.06-1.77),高于腹腔镜绝育术组;术后1年两种方法无显著差异。

关键数值与推荐

  • 宫腔镜绝育术组1年内重复绝育索赔调整发生率比3.48(95%CI 2.69-4.27),5年内2.32(95%CI 1.84-2.79),均以腹腔镜绝育术组为参照。
  • 宫腔镜绝育术组2年盆腔痛索赔调整发生率比0.77(95%CI 0.65-0.92),7-12个月腹痛0.80(95%CI 0.68-0.93),2年盆腔炎性疾病0.55(95%CI 0.33-0.93)。
  • 宫腔镜绝育术组术后7-12个月异常子宫出血索赔调整发生率比1.37(95%CI 1.06-1.77),术后1年两种方法无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the real-world safety of hysteroscopic compared with laparoscopic surgical sterilization. METHODS: We conducted a retrospective cohort study of Medicaid claims for hysteroscopic or laparoscopic sterilization procedures performed in California, 2008-2014, among women aged 18-50 years. After excluding postpartum procedures, we applied log-linear (Poisson) event-history regression models for clustered person-period data, weighted for propensity to receive either sterilization procedures, and adjusted for sociodemographic and clinical characteristics that may affect outcomes of interest to patients and physicians. We assessed the following outcomes: procedural complications, additional surgical procedures (eg, hysterectomy), repeat sterilization procedures, pelvic pain, pelvic inflammatory disease (PID), abdominal pain, nonabdominal pain, and abnormal uterine bleeding. RESULTS: We identified 5,906 women who had undergone hysteroscopic and 23,965 who had undergone laparoscopic sterilization. After adjusting for sociodemographic and health history, women who had hysteroscopic sterilization were less likely to have claims for procedural complications (eg, transfusion, P<.001) on the day of surgical sterilization and additional surgical procedures (eg, hysterectomy, P=.002 at day 2-3 months postprocedure) than laparoscopic sterilization. Claims for a repeat attempt at sterilization were more common after hysteroscopic sterilization within 1 year (adjusted incident rate ratio 3.48, 95% CI 2.69-4.27) and within 5 years (adjusted incident rate ratio 2.32, 95% CI 1.84-2.79) than laparoscopic sterilization. Claims for pelvic pain (adjusted incident rate ratio 0.77, 95% CI 0.65-0.92 at 2 years), abdominal pain (adjusted incident rate ratio 0.80, 95% CI 0.68-0.93 at 7-12 months), and PID (adjusted incident rate ratio 0.55, 95% CI 0.33-0.93 at 2 years) were less common after hysteroscopic than laparoscopic sterilization. Although abnormal uterine bleeding claims were more common after hysteroscopic than laparoscopic sterilization up to 12 months postprocedure (adjusted incident rate ratio 1.37, 95% CI 1.06-1.77 at 7-12 months), there were no significant differences between methods 1 year after the procedure. CONCLUSION: Compared with laparoscopic sterilization, hysteroscopic sterilization was followed by more claims for repeat sterilization procedures and abnormal uterine bleeding, but fewer procedural complications and fewer claims for pelvic or abdominal pain. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT03438682.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Gariepy AM, Lewis C, Zuckerman D, et al. Patient-Centered Safety Outcomes After Hysteroscopic Compared With Laparoscopic Sterilization. Obstet Gynecol. 2022. PMID: 35115444. doi:10.1097/AOG.0000000000004690

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。